MedPath

Efficacy of moisturizer and acquisition of basic dermatological data in skin adverse event of epidermal growth factor receptor inhibitors.

Phase 2
Conditions
ung cancer
Registration Number
JPRN-UMIN000006360
Lead Sponsor
Kyushu University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1.Person with skin disorder with wide body surface area. 2.Person with allergy to this moisturizer. 3.Person with severe bleeding tendency. 4.person who is judged as improper as included by the doctors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acquisition of basic dermatological data of the patients taking EGFR inhibitors.
Secondary Outcome Measures
NameTimeMethod
The efficacy and safety of moisturizer for skin adverse events of EGFR inhibitors.
© Copyright 2025. All Rights Reserved by MedPath